As Pfizer and Moderna edge closer to regulatory approval, access—and herd immunity—hinges on affordability.
Category: Policy
Medical Associations Urge Trump To Share Coronavirus Information With Biden Transition Team
The agency responsible for the transition has refused to start working with the Biden team, and the president has not conceded.
Former FDA Commissioner Says Pandemic Could ‘Effectively End In 2021’ If Pfizer, Moderna Vaccines Live Up To Early Data
Early data has indicated Pfizer’s vaccine could be up to 90% effective and Moderna’s could be more than 94% effective.
WHO Chief Warns Vaccine Won’t End Covid-19 Pandemic As Moderna, Pfizer Announce Early Successes
The public health leader stressed the need to continue other methods of disease control, like contact tracing, isolating infected patients and testing.
Michigan, Washington Order New Covid-19 Restrictions As U.S. Cases Surge Past 11 Million
The U.S. has reported more than a million new cases in less than a week.
A call for more handicap accessible options for homeless patients in Rhode Island
“I’ve been left out here to die ever since my legs were cut off,” he said joylessly. He was a gruff, elderly man, sharp as a tack, bundled in tattered blankets. His below-knee amputations were tucked away in his cramped wheelchair. This man had been st…
Pfizer Has A Head Start, But The Covid-19 Vaccine Market Is Still Up For Grabs
Any first-mover advantage won’t last long, as some vaccine candidates may be easier to transport and administer than others.
Virus Fighter Peter Piot: On The Road To A Covid-19 Vaccine
Renowned virologist Peter Piot calls the pandemic “the biggest crisis in peacetime we have known.”
The UK Tops 50,000 Coronavirus-Related Deaths, Most Of Any European Country
The UK is the fifth country to pass the grim milestone.
CDC Strengthens Mask Guidance To Say It Also Protects Wearer
Mask-wearing has become politicized despite research showing the benefits.
